Category: MS Drug Therapies

Featured image for “Gabapentinoids, yet another dirty secret”

Gabapentinoids, yet another dirty secret

Some people with MS are on ten or more concomitant medications including gabapentin or pregabalin. Are you? Gavin Giovannoni –…

Stuart Schlossman

Featured image for “Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms”

Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms

September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…

Stuart Schlossman

New Novartis data in relapsing MS reinforce benefits of Kesimpta® for first-line and switch patients

Sep 18, 2024 East Hanover, September 18, 2024 – Novartis today announced new data from the ALITHIOS open-label extension study. Data…

Stuart Schlossman

Press Release: FDA Approves Ocrevus Zunovo™ as the First and Only Twice-a-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis

Ocrevus Zunovo™ has the potential to expand treatment options to centers without IV infrastructure or with IV constraints, like at a…

Stuart Schlossman

Featured image for “Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis”

Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis

September 2, 2024 • In the HERCULES study, tolebrutinib met the primary endpoint in delaying time to onset of confirmed…

Stuart Schlossman

Featured image for “Why BOTHER taking MS Medications?”

Why BOTHER taking MS Medications?

No excerpt…

Stuart Schlossman

Featured image for ““MS101, The Basics” with Aaron Boster, MD”

“MS101, The Basics” with Aaron Boster, MD

At the 2024 MS WELLNESS SUMMIT, Doctor Aaron Boster, MD an MS Neurologist, discusses his 6-for-6 for YOUR care in…

Stuart Schlossman

Featured image for “Prescription Assistance”

Prescription Assistance

If you need help paying for your medication, our guide can help you find the right assistance. This guide was…

Stuart Schlossman

Different lymphocyte counts of ms patients treated with ofatumumab and ocrelizumab

Christoph Friedli 1 2, Nik Krajnc 3 4, Helly N Hammer 1, Stefanie Marti 1, Tobias Zrzavy 3 4, Maria E Evangelopoulos 5, Ioanna Kapsali 5, Paulus Rommer 3 4, Thomas Berger 3 4, Andrew Chan 1, Gabriel Bsteh 3 4, Robert Hoepner 1 Affiliations expand Abstract Introduction: Patients with Multiple…

Stuart Schlossman

Featured image for “Breaking news: Committee favors approval of under-the-skin Ocrevus in Europe”

Breaking news: Committee favors approval of under-the-skin Ocrevus in Europe

By: Andrea Lobo, PhD — Written – April 30, 2024 New formulation recommended by CHMP would be faster, easier for…

Stuart Schlossman

Categories

Latest Blog Posts